Mysulin Injection 50%+50% is a premixed insulin formulation containing Regular Insulin Human 50% (short-acting) and Isophane Insulin Human 50% (intermediate-acting) in a concentration of 100 IU/ml. This balanced mixture provides both rapid postprandial (after meals) glucose control and basal insulin coverage in a single injection, offering convenience and effective management of diabetes mellitus.
The Regular Insulin Human component acts quickly to reduce blood sugar spikes following meals, while the Isophane Insulin Human component provides a slower, prolonged effect to maintain basal glucose levels throughout the day. By combining equal proportions of short-acting and intermediate-acting insulin, Mysulin 50%+50% allows flexibility in dosing and simplifies therapy for patients requiring consistent glycemic control.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Mysulin Injection 50%+50% is indicated for:
Type 1 diabetes mellitus – for patients needing both basal and prandial insulin coverage
Type 2 diabetes mellitus – when oral antidiabetic agents alone do not provide adequate glycemic control
Management of fasting and postprandial hyperglycemia in diabetic patients
Patients requiring a premixed insulin regimen to reduce the number of daily injections
This formulation is suitable for adults and adolescents and is intended for individualized therapy under the guidance of a healthcare professional.
Rapid-acting component controls post-meal blood sugar spikes
Intermediate-acting component maintains basal glucose levels throughout the day
Simplifies insulin therapy by combining two insulin types in one injection
Reduces risk of long-term diabetes complications, including neuropathy, retinopathy, and cardiovascular disease
Convenient for home use, travel, and daily schedules requiring fewer injections
Mysulin Injection 50%+50% ensures consistent blood glucose management, improving patient adherence and overall quality of life.
Dosage must be individualized based on blood glucose levels, diet, physical activity, and other medications.
Administer subcutaneously in the abdomen, thigh, or upper arm; rotate injection sites to prevent lipodystrophy.
Typically given one to two times daily, usually before meals, as prescribed by a physician.
Do not mix with other insulin types unless specifically advised by a healthcare provider.
Regular blood glucose monitoring is essential to adjust the dose and avoid hypo- or hyperglycemia.
Hypoglycemia is a possible risk; recognize early symptoms such as sweating, dizziness, shakiness, or palpitations.
Adjust dosage during illness, changes in diet, increased physical activity, or stress.
Inform your doctor about all medications to prevent interactions affecting blood glucose.
Pregnant or breastfeeding women should use this injection under medical supervision.
Always keep a fast-acting sugar source nearby for emergency management of hypoglycemia.
Mysulin Injection 50%+50% is generally well tolerated. Possible side effects include:
Hypoglycemia (low blood sugar)
Injection site reactions such as redness, swelling, or mild pain
Weight gain with prolonged therapy
Rare allergic reactions, including rash or anaphylaxis
Most side effects are manageable with proper monitoring, dose adjustment, and adherence to the prescribed regimen.
Store unopened vials in a refrigerator at 2–8°C. Do not freeze.
After opening, it may be kept at room temperature (below 30°C) for the duration advised by the physician.
Protect from light and moisture, and keep out of reach of children.
Mysulin Injection 50%+50% (Regular Insulin Human + Isophane Insulin Human) is a reliable premixed insulin that provides balanced rapid and intermediate action, helping patients achieve stable blood glucose control and effective diabetes management.
Login Or Registerto submit your questions to seller
No none asked to seller yet